United States Cardiovascular Surgery Devices Market Outlook to 2025
Summary GlobalData’s new report, "United States Cardiovascular Surgery Devices Market Outlook to 2025", provides key market data on the United States Cardiovascular Surgery Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Beating Heart Surgery Systems, Cardiopulmonary Bypass Equipment, Chest Drainage Catheters and Units and Perfusion Disposables.
The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.
Scope - Market size and company share data for Cardiovascular Surgery Devices market segments - Beating Heart Surgery Systems, Cardiopulmonary Bypass Equipment, Chest Drainage Catheters and Units and Perfusion Disposables. - Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2015 to 2025. - 2017 company share and distribution share data for Cardiovascular Surgery Devices market. - Global corporate-level profiles of key companies operating within the United States Cardiovascular Surgery Devices market. - Key players covered include Medtronic plc, LivaNova PLC, Terumo Corp. and Others.
Reasons to buy - Develop business strategies by identifying the key market segments poised for strong growth in the future. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the market. - Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
Our reports have been used by over 10K customers, including:
The major factors attributing to the growth of the Infertility Treatment Devices market are significant changes in lifestyle which contributed to the rise in infertility and prevalence of conditions such as Polycystic Ovary Syndrome (PCOS). Also, a constant increase in the incidence of infertility in both sexes is projected to drive the market....
On the rebound: Medicare reimbursement caps for physical therapy may constrain revenue growth Abstract Physical Therapists in the US Over the five years to 2019, the role of physical therapy in promoting health and wellness has increased, benefiting this industry. As the number of individuals aged...
Taken care of: A growing and aging population will lead to steady sector revenue growth Abstract Healthcare and Social Assistance in the US The Healthcare and Social Assistance sector has steadily grown over the past five years. The majority of services offered by subsectors in the industry, which includes...
The United States Behavioral Rehabilitation market studied was projected to grow with a CAGR of 2.5% over the forecast period. The market is driven by factors, such as the growing number of rehabilitation centres across the country, and the increasing prevalence of behavioural disorders and drug abuse. With the evolution done in behavioural...
Positive prognosis: Greater public and private health spending has boosted demand for industry products
Online Medical Supplies Sales
The Online Medical Supplies Sales industry has boomed over the five years to 2018 due to favorable demographics boositng demand for industry services. As...
Biodecontamination market to register a CAGR of 6.1% from 2019 to 2024. The biodecontamination market is projected to reach USD 175 million by 2024 from USD 130 million in 2019, at a CAGR of 6.1% from 2019 to 2024. The growth of the market is largely driven by the rising incidence of hospital-acquired infections (HAIs),...
Summary Prime Healthcare Services Inc (Prime Healthcare) is a hospital management center that operates acute care hospitals.The center provides medical services such as emergency room, senior services, heart care services, behavioral health services, and others. It offers surgical services, wound healing center,...
Summary Mednax Inc (Mednax) is a national medical group company, which operates a network of physician service providers.The company offers a wide range of neonatal, anesthesia, maternal-fetal, pediatric physician and subspecialty services. Its network includes other pediatric subspecialists comprising physicians...
The global sinus dilation devices market projected to grow at a CAGR of 9.1%. The global sinus dilation devices market is expected to reach USD 2.78 billion by 2023 from USD 1.80 billion in 2018, at a CAGR of 9.1%. High prevalence of chronic sinusitis, growing preference for minimally invasive procedures, benefits of balloon sinuplasty/sinus...
74 pages •
By Infiniti Research Limited
• Dec 2016
About Human Respiratory Syncytial Virus Drugs Respiratory syncytial virus (RSV) is a virus that leads to infections in the lungs and the respiratory tract. It commonly affects most children in the ages 2 or below. RSV can also infect adults. In adults and the older population, the symptoms of RSV are mild and similar to that of common...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.